Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: A randomized, double-blind, placebo-controlled study

Otology and Neurotology

Volumn 32, Issue 5, 2011, Pages 774-779

  Wu, Hung Pin ^a,b   Chou, Yi Fan ^c   Yu, Szu Hui ^d   Wang, Cheng Ping ^e   Hsu, Chuan Jen ^e   Chen, Peir Rong ^a,f  

^a Buddhist Tzuchi General Hospital   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAINAN UNIVERSITY OF TECHNOLOGY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Double blind clinical trial; Intratympanic injection; Steroid; Sudden sensorineural hearing loss

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; AUDITORY THRESHOLD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EARDRUM; FEMALE; HUMAN; INJECTION; MALE; MIDDLE AGED; PERCEPTION DEAFNESS; PROSPECTIVE STUDY; PURE TONE AUDIOMETRY; RANDOMIZED CONTROLLED TRIAL; SALVAGE THERAPY; SUDDEN DEAFNESS; TREATMENT OUTCOME;

ADULT; AGED; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; DEXAMETHASONE; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; TYMPANIC MEMBRANE;

EID: 79959983472     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e31821fbdd1     Document Type: Article

References (37)

1. De Kleyn A. Sudden complete or partial lossof function of octavus system in apparently normal persons. Acta Otol 1944;32:407-29.
2. National Institutes of Health. Sudden Deafness. Bethesda, MD: National Institutes of Health 2000. Publication no. 00-4757.
3. Byl FM Jr. Sudden hearing loss: eight years' experience and sug-gested prognostic table. Laryngoscope 1984;94:647-61. (Pubitemid 14105743)
4. Wilson WR, Veltri RW, Laird N, et al. Viral and epidemiologic studies of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 1983;91:653-8. (Pubitemid 14206282)
5. Kellerhals B. Acoustic trauma and cochlear microcirculation. An experimental and clinical study on pathogenesis and treatment of inner ear lesions after acute noise exposure. Adv Otorhinolaryngol 1972;18:91-168.
6. Probst R, Tschopp K, Ludin E, et al. A randomized, double-blind, placebo-controlled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Otolaryngol 1992;112: 435-43.
7. Campbell KC, Klemens JJ. Sudden hearing loss and autoimmune inner ear disease. JAm AcadAudiol 2000;11:361-7.
8. Reisser CH, Weidauer H. Ginkgo biloba extract EGb 761 or pen-toxifylline for the treatment of sudden deafness: a randomized, reference-controlled, double-blind study. Acta Otolaryngol 2001; 121:579-84. (Pubitemid 32831798)
9. Ogawa K, Takei S, Inoue Y, et al. Effect of prostaglandin E1 on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study. Otol Neurotol 2002;23:665-8.
10. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment ofidiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980;106:772-6. (Pubitemid 11194190)
11. Mort DJ, Bronstein AM. Sudden deafness. Curr Opin Neurol 2006;19:1-3. (Pubitemid 43172698)
12. Leong AC, Fairley JW, Padgham ND. Sudden hearing loss. Clin Otolaryngol 2007;32:391-4. (Pubitemid 47460289)
13. Chandrasekhar SS. Intratympanic dexamethasone for sudden sen-sorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001;22:18-23. (Pubitemid 32182848)
14. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinet-ics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:1-17. (Pubitemid 29315126)
15. Ho HG, Lin HC, Shu MT, et al. Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope 2004;114:1184-9.
16. Light JP, Silverstein H. Transtympanic perfusion: indications and limitations. Curr Opin Otolaryngol Head Neck Surg 2004;12:378-83. (Pubitemid 39287563)
17. Herr BD, Marzo SJ. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005;132:527-31. (Pubitemid 40460877)
18. Slattery WH, Fisher LM, Iqbal Z, et al. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolar-yngolHeadNeck Surg 2005;133:251-9. (Pubitemid 41125677)
19. Xenellis J, Papadimitriou N, Nikolopoulos T, et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 2006;134:940-5. (Pubitemid 43766563)
20. Haynes DS, O'Malley M, Cohen S, et al. Intratympanic dexameth-asone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007;117:3-15. (Pubitemid 46066055)
21. Serin GM, Ciprut A, Baylancicek S, et al. Ototoxic effect of Burow solution applied to the guinea pig middle ear. Otol Neurotol 2007; 28:605-8. (Pubitemid 47229705)
22. Silverstein H, Choo D, Rosenberg SI, et al. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose ThroatJ 1996;75:468-71, 74, 76 passim.
23. Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. OtolNeurotol2005;26:878-81. (Pubitemid 41330701)
24. Plaza G, Herraiz C. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg 2007;137:74-8. (Pubitemid 46962140)
25. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463-80. (Pubitemid 8161819)
26. Rauch SD. Intratympanic steroids for sensorineural hearing loss. Otolaryngol Clin North Am 2004;37:1061-74. (Pubitemid 39335773)
27. Choung YH, Park K, Shin YR, et al. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Laryngo-scope 2006;116:747-52. (Pubitemid 44318031)
28. Hughes GB, Freedman MA, Haberkamp TJ, et al. Sudden sensori-neural hearing loss. Otolaryngol Clin North Am 1996;29:393-405.
29. Bennett M, Kertesz T, Yeung P. Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss and tinnitus: a sys-tematic review of randomized controlled trials. J Laryngol Otol 2005;119:791-8. (Pubitemid 41502914)
30. Yeo SW, Lee DH, Jun BC, et al. Hearing outcome of sudden sen-sorineural hearing loss: long-term follow-up. Otolaryngol Head Neck Surg 2007;136:221-4.
31. Psifidis AD, Psillas GK, Daniilidis J. Sudden sensorineural hearing loss: long-term follow-up results. Otolaryngol Head Neck Surg 2006;134:809-15.
32. Cinamon U, Bendet E, Kronenberg J. Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. EurArch Otorhinolaryngol 2001;258:477-80. (Pubitemid 33141264)
33. Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008;29:453-60.
34. Schuknecht HF. Ablation therapy for the relief of Ménière disease. Laryngoscope 1956;66:859-70.
35. Shirwany NA, Seidman MD, Tang W. Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 1998;19:230-5. (Pubitemid 28152582)
36. Chang NC, Ho KY, Kuo WR. Audiometric patterns and prognosis in sudden sensorineural hearing loss in southern Taiwan. Otolar-yngol Head Neck Surg 2005;133:916-22.
37. Weng SF, Chen YS, Hsu CJ, et al. Clinical features of sudden sensorineural hearing loss in diabetic patients. Laryngoscope 2005;115:1676-80.